106 related articles for article (PubMed ID: 15684607)
1. Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response.
Carbone A; Rodeck U; Mauri FA; Sozzi M; Gaspari F; Smirne C; Prati A; Addeo A; Novarino A; Robecchi A; Bertetto O; Emanuelli G; Bellone G
Cancer Biol Ther; 2005 Feb; 4(2):231-41. PubMed ID: 15684607
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells.
Martone T; Bellone G; Pagano M; Beatrice F; Palonta F; Emanuelli G; Cortesina G
Head Neck; 2004 Jun; 26(6):494-503. PubMed ID: 15162350
[TBL] [Abstract][Full Text] [Related]
3. IL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survival.
Carbone A; Vizio B; Novarino A; Mauri FA; Geuna M; Robino C; Brondino G; Prati A; Giacobino A; Campra D; Chiarle R; Fronda GR; Ciuffreda L; Bellone G
J Immunother; 2009; 32(9):920-31. PubMed ID: 19816189
[TBL] [Abstract][Full Text] [Related]
4. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
5. Expression of interleukin-18 in human ovarian carcinoma and normal ovarian epithelium: evidence for defective processing in tumor cells.
Wang ZY; Gaggero A; Rubartelli A; Rosso O; Miotti S; Mezzanzanica D; Canevari S; Ferrini S
Int J Cancer; 2002 Apr; 98(6):873-8. PubMed ID: 11948465
[TBL] [Abstract][Full Text] [Related]
6. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
7. A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing.
Gaggero A; De Ambrosis A; Mezzanzanica D; Piazza T; Rubartelli A; Figini M; Canevari S; Ferrini S
Oncogene; 2004 Sep; 23(45):7552-60. PubMed ID: 15326478
[TBL] [Abstract][Full Text] [Related]
8. Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil.
Wu XX; Kakehi Y; Mizutani Y; Lu J; Terachi T; Ogawa O
Int J Oncol; 2001 Jul; 19(1):19-24. PubMed ID: 11408917
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia trachomatis infection of epithelial cells induces the activation of caspase-1 and release of mature IL-18.
Lu H; Shen C; Brunham RC
J Immunol; 2000 Aug; 165(3):1463-9. PubMed ID: 10903751
[TBL] [Abstract][Full Text] [Related]
10. Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2.
Bellone G; Carbone A; Busso V; Scirelli T; Buffolino A; Smirne C; Novarino A; Bertetto O; Tosetti L; Emanuelli G
Cancer Biol Ther; 2006 Oct; 5(10):1294-303. PubMed ID: 16929163
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis of colorectal adenocarcinoma induced by 5-FU and/or IFN-gamma through caspase 3 and caspase 8.
Adachi Y; Taketani S; Oyaizu H; Ikebukuro K; Tokunaga R; Ikehara S
Int J Oncol; 1999 Dec; 15(6):1191-6. PubMed ID: 10568827
[TBL] [Abstract][Full Text] [Related]
12. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
[TBL] [Abstract][Full Text] [Related]
13. Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation.
Pirhonen J; Sareneva T; Julkunen I; Matikainen S
Eur J Immunol; 2001 Mar; 31(3):726-33. PubMed ID: 11241276
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.
Kumar S; Hanning CR; Brigham-Burke MR; Rieman DJ; Lehr R; Khandekar S; Kirkpatrick RB; Scott GF; Lee JC; Lynch FJ; Gao W; Gambotto A; Lotze MT
Cytokine; 2002 Apr; 18(2):61-71. PubMed ID: 12096920
[TBL] [Abstract][Full Text] [Related]
15. Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes.
Coward WR; Marei A; Yang A; Vasa-Nicotera MM; Chow SC
J Immunol; 2006 May; 176(9):5284-92. PubMed ID: 16621994
[TBL] [Abstract][Full Text] [Related]
16. Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer.
Niccolai E; Taddei A; Ricci F; Rolla S; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Pini A; Castiglione F; Giordano D; Satolli MA; Coratti A; Cianchi F; Bani D; Prisco D; Novelli F; Amedei A
Clin Sci (Lond); 2016 Feb; 130(4):247-58. PubMed ID: 26590104
[TBL] [Abstract][Full Text] [Related]
17. Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives.
Takamura M; Nio Y; Yamasawa K; Dong M; Yamaguchi K; Itakura M
Anticancer Drugs; 2002 Jan; 13(1):75-85. PubMed ID: 11914644
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-18 by nasopharyngeal carcinoma cells: a factor that possibly initiates the massive leukocyte infiltration.
Hu H; Tang KF; Chua YN; Lu J; Feng P; Chew CT; Chan SH
Hum Pathol; 2004 Jun; 35(6):722-8. PubMed ID: 15188138
[TBL] [Abstract][Full Text] [Related]
19. CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma.
Wang XS; Sheng Z; Ruan YB; Guang Y; Yang ML
World J Gastroenterol; 2005 Feb; 11(8):1220-4. PubMed ID: 15754409
[TBL] [Abstract][Full Text] [Related]
20. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes.
Bergmann-Leitner ES; Abrams SI
Cancer Immunol Immunother; 2001 Nov; 50(9):445-55. PubMed ID: 11761438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
